At Religen Labs
Who We Are
Religen Dx is a dynamic life sciences company that develops and implements new and innovative diagnostic testing. The primary objective of our testing is to identify biomarkers in order to enable and facilitate appropriate intervention and treatment at the earliest possible stages. At Religen, we believe that reliable diagnostics are the cornerstone for effective prevention, mitigation, treatment, and healing.
Inspired innovations in diagnostic testing to inform, educate, and guide every patient towards optimal health.
Mitochondrial Disease and Dysfunction, Cardiovascular Disease, Neurodevelopmental / Neurodegenerative Disease, Genetics.
Learn about our current diagnostics testing
Buccal Swab Test to analyze the Mitochondrial Electron Transport Chain Complex (ETC I, II, III, IV)
Mitochondrial DNA Sequencing
1 in 6 children in the United States were diagnosed with a Developmental Disability in 2006-2008, ranging from mild disabilities such as speech and language impairments to serious Developmental Disabilities, such as Intellectual Disabilities, Cerebral Palsy, and Autism.
5.8 Million Americans are Living with Alzheimer’s Disease.
121.5 Million Americans, or about 48.5 percent of the population, have heart or blood vessel disease.
What do these statistics have to do with Religen Dx?
Our testing directly addresses researched diagnosis of these conditions on a cellular and molecular level. Testing at these levels allows for individualized results and treatments, leading physicians and patients towards optimal personalized health.
Get in Touch
Send a message